(CSL:Australian Stock Exchange Ltd)
Andrew Cuthbertson BMedSci, MBBS, Ph.D.
Chief Scientific officer and Director of R&D, CSL Ltd.
|Age||Total Calculated Compensation||This person is connected to 2 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Andrew Cuthbertson, BMedSci, MBBS, Ph.D., has been Chief Scientific officer and Director of R&D at CSL Ltd. since 2000. Dr. Cuthbertson serves as Chief Scientific Officer of CSL Behring LLC and has been its R&D Director since March 2000, where Dr. Cuthbertson is responsible for the global operations of Research and Development (R&D). Dr. Cuthbertson manages an internal R&D budget of over $350m, and a global R&D organisation of 800 scientists. He is responsible for ...
45 Poplar RoadPhone: 61 3 9389 1911
Parkville, Victoria 3052
Fax: 61 3 9389 1434
Board Members Memberships*
Walter and Eliza Hall Institute
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|Victor Grifols Roura||Chairman, Chief Executive Officer and Member of Appointments and Remuneration Committee|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|¥170.0M||Compensation as of Fiscal Year 2013.|